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Resident macrophages (MO)' are widely distributed throughout tissues ofadult
animals, even in the absence of overt inflammation or infection. At portals of
entry they may play a role in innate resistance to infection, but in other sites,
particularly hematopoietic and lymphoid tissues where stromal MO are relatively
abundant (1-3), their precise functionsare less clear. It is possible, however, that
in addition to scavenging worn-out and damaged cells and ingesting erythrocyte
nuclei, stromal Mo in these tissues may play a regulatory role in cellular prolif-
eration and differentiation. Support for this possibility has come from studies on
bone marrow and thymus (2-5). In both cases, stromal M(k establish intimate
physical associations in situ with immature hematopoietic cells or thymocytes (2,
3). After enzymatic dispersion of the tissues, it is possible to obtain clusters that
contain Mo and attached cells (4, 5). To date, there have been few attempts to
determine the functional importance of cluster formation in these tissues or to
characterize the receptors and ligands involved. To carry out such studies, it is
necessary to isolate the relevant M0, rather than to use a more easily obtained
population such as peritonea[ MO, which may differ substantially in function and
properties (5).
We recently described (5) a method for isolating resident MO from murine
bone marrow (RBMM), in reasonable yieldand purity, which allowed us to study
the properties of RBMM (5). When their phenotype was compared with that of
resident peritoneal MO (RPM), we found both quantitative and qualitative
differences in expression of various antigens and receptors. The most striking
difference was the ability ofRBMM, but not RPM, to bind unopsonized sheep E
without ingestion. In view of the possibility that this novel E receptor (SER)
could be involved in Mo-binding to hematopoietic cells in murine bone marrow,
it seemed important to characterize it further. In the present paper we show that
SER on RBMM is a lectin-like agglutinin with specificity for sialylated compo-
nent(s) on E. Our studies show that SER is also expressed on stromal Mo isolated
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from lymph node, liver, and spleen, but is at low levels or undetectable on
monocytes and Mo isolated from thymus, peritoneal cavity, pleural cavity, and
bronchoalveolar spaces. The presence of SER on selected stromal but not "free"
M(P populations suggests that this hemagglutinin may be involved in adhesive
interactions within tissues.
Materials and Methods
Animals.
￿
Mice were bred at the Sir William Dunn School of Pathology, University of
Oxford and both sexes were used between 8 and 12 wk of age.
Media and Reagents. RPMI 1640 was obtained from Gibco-Biocult Ltd., Paisley,
United Kingdom. FCS was obtained from Seralab UK Ltd., Crawley Down, United
Kingdom, and was routinely heat inactivated for 30 min at 56 ° C. Media were supple-
mented with glutamine (2 mM) and gentamicin (20 kg/ml). PBS without calcium or
magnesium was obtained from Oxoid Ltd., Basingstoke, United Kingdom. Hepes buffer
was purchased from Gibco-Biocult Ltd. Collagenase was purchased from Boehringer
Corp., Lewes, United Kingdom; and DNase (type 1), trypsin (type IX), and Staphylococcus
aureus protease (type XV11) were from Sigma Chemicals Ltd., Poole, United Kingdom.
Neuraminidase (Vibrio cholerae) was obtained from BDH Ltd., Poole, England (500 U/ml),
or from Calbiochem-Behring Corp., La Jolla, Ca. (1 Behringwerke unit/ml). Mono- and
disaccharides were purchased from Sigma Chemicals Ltd. The trisaccharide, N-acetylneu-
raminyllactose (NANA-lactose) was obtained from either Sigma Chemicals Ltd. or from
Boehringer Corp. From Sigma Chemicals Ltd. we purchased NANA-lactose purified from
either bovine colostrum (85% 2,3-Neu-5-AcLac) or from human colostrum (85% 2,6-
Neu-5-AcLac). The bovine form was also purchased from Boehringer Corp. The ganglio-
sides GM I and GDIa, purified from bovine brain, were generously provided by Dr. J.
Mellanby, Department of Experimental Psychology, Oxford University. The neoglyco-
conjugates, mannosylated BSA, and galactosylated BSA, with 33-37 moles of sugar per
mole protein, were kind gifts of Dr. P. Stahl, Washington University, St. Louis, MO.
Ovine submaxillary mucin, prepared according to Hill et al . (6), and ovine orosomucoid
(Sigma Chemicals Ltd.) were generously provided by Dr. K. McCusker, Washington
University, St. Louis, MO. Fetuin (type III) was purchased from Sigma Chemicals Ltd.
Sodium azide and the disodium salt of tetraacetic acid EDTA were from Sigma Chemicals
Ltd. Sodium iodoacetate was from BDH Ltd. Sheep E, in Alsevers solution, were
purchased from Gibco Biocult Ltd., stored at 4°C, and used within 2 wk.
Antibodies. The following mAbs were obtained as shown and used at saturation as
concentrated supernatants: F4/80, a rat mAb specific for mature mouse MO (7); M1/70,
which binds to Mac-1, an epitope of the iC3b receptor (CR3) on mouse neutrophils, MO
and NK cells (8; Dr. T. Springer, Harvard Medical School, Boston, MA); M5/114, a rat
anti-mouse mAb that recognizes Ia antigens (1-Ac.d,91-Ed,k) (9; Dr. H. Waldmann, Depart-
ment of Pathology, University of Cambridge, United Kingdom); and 2AG2 a rat mAb
directed to the trypsin resistant FcR for IgGl/2b isotypes (10; Dr. J . Unkeless, The
Rockefeller University, New York).
Isolation ofMo Populations.
￿
RBMM were isolated from mouse femoral marrow plugs
as described previously (5). Briefly, plugs from 12 femora were digested with 0.05%
collagenase and 0.001% DNase dissolved in RPMI. The resulting clusters, containing
RBMM, were purified from single cells by velocity sedimentation and were allowed to
adhere to 24 X 11 mm diameter coverslips for 2-3 h at 37 °C, 5% C02, in a fully
humidified incubator. RBMM were then stripped free of clustering cells by prior incuba-
tion in PBS followed by gentle direct flushing.
All peritoneal Mo populations were obtained by lavage with 6 ml of PBS. RPM were
harvested from unstimulated mice, inflammatory peritoneal Mo were from mice injected
intraperitoneally 4-5 d previously with 1 ml of Brewers thioglycollate broth (Difco, E.
Mosely, United Kingdom), and immunologically activated peritoneal MO were obtained
from mice injected intraperitoneafy 12 d previously with either 10' live Bacillus Calmette-
Guerin BCG organisms (Pasteur strain 1011 ; kindly provided by Dr. R. North, Trudeau1864
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Institute, Saranac Lake, NY) or killed Corynebacterium parvum (Wellcome Biotechnology
Ltd., Beckenham, United Kingdom).
Resident pleural M¢ were obtained from unstimulated mice by pleural lavage with 2
ml of PBS. Bronchoalveolar M¢ were obtained by tracheal cannulation followed by lavage
with 5 X 1-ml aliquots of PBS. Peritoneal, pleural, and bronchoalveolar MO were washed
once in PBS and plated onto I 1-mm glass coverslips at a density of 105 cells per coverslip
in I ml RPMI plus 10% FCS. After 60 min at 37°C, nonadherent cells were removed by
gentle, direct pipetting with RPMI . The adherent cells were then cultured in RPMI plus
10% FCS before rosetting assays.
Spleen adherent cells were obtained from collagenase-perfused spleens as described
(11). The cell suspension from one spleen was distributed among eight coverslips, and
after 2-3 h at 37°C, nonadherent cells were removed by direct pipetting. Kupffer cells
were obtained from collagenase-perfused livers as described (11). The nonparenchymal
cell fraction from each liver was plated onto eight coverslips in RPMI plus 10% FCS, and
nonadherent cells were removed by pipetting after 30 min at 37°C to minimize contam-
ination by endothelial cells. Thymic and mesenteric lymph node-adherent cells were
obtained by mincing tissues from one mouse in 20 ml RPMI plus 0.05% collagenase and
0 .001% DNase, and digesting them at 37°C for 60 min with constant rotation at 25 rpm.
on a 17-cm diameter rotary wheel. Undigested material was discarded and cell suspensions
were washed twice in RPMI by centrifugation for 10 min at 200 g. The cells were
resuspended in RPMI plus 10% FCS and plated onto four coverslips. Nonadherent cells
were removed after 2 h at 37 0 C.
Isolation ofMonocytes.
￿
Mice were killed with C02 and bled by cardiac puncture using
10% acid citrate dextrose or 10 U/ml heparin (Flow Laboratories, Irvine, United King-
dom) as anticoagulants. Buffy coat, obtained by centrifugation of blood at 100 g for 15
min, was suspended in 2 ml PBS and layered onto 8 ml of Lympholyte M (Sera-Lab Ltd.,
Crawley Down, United Kingdom). After centrifugation for 40 min at 400 g, the mono-
nuclear cells at the interface were collected and washed four times at 200 g for 10 min to
remove platelets. Cells were finally suspended in RPMI plus 10% FCS at 106 cells per ml
and 1-ml aliquots added to coverslips. After 60 min at 37°C, nonadherent cells were
removed by repeated, direct pipetting.
Opsonization ofE with IgG.
￿
E were washed four times in PBS by centrifugation at 500
g for 5 min, were resuspended at 5% vol/vol in RPMI plus 1 % FCS and incubated for 30
min at 37°C with a subagglutinating concentration of rabbit anti-E IgG (Nordic Immu-
nological Laboratories, Tilburg, The Netherlands). Opsonized E (EIgG) were then washed
four times in PBS before use .
E . and EIgG Rosetting Assays.
￿
Coverslips with adherent cells were rinsed three times by
immersion in RPM] and placed in 0.5 ml RPMI, with or without inhibitors, in a 24-well
tissue culture dish. EIgG or E, washed four times with PBS by centrifugation for 5 min at
400 g, were resuspended in RPMI at 5% vol/vol and 50 Al of the suspensionadded to the
coverslips and were mixed by swirling. After 30 min at 37°C (or the temperature under
test), unbound E or EIgG were removed by immersing coverslips three times in each of
four beakers of RPMI. In between each beaker the excess fluid on coverslips was drained
by touching the edge on tissue paper. After the final rinse, coverslips were placed in 1 ml
of 1 % vol/vol glutaraldehyde in PBS and stored at 4'C until examination by phase-
contrast microscopy. In some experiments, ingestion of E was assessed after lysing bound
E by immersing coverslips in 10 mM phosphate buffer (pH 7 .2) for 10 s. For immunocy-
tochemistry (see below) cells were fixed in 0.25% glutaraldehyde for 10 min at room
temperature and then rinsed three times in PBS. Assays were routinely carried out in
duplicate; a cell was considered positive for SER if ?5 E were attached. Usually, 200 MO
were scored on each coverslip.
In some experiments, rosetting was carried out in suspension as follows: splenic or bone
marrow cells and clusters obtained by collagenase digestion were incubated at 4°C in PBS
containing 5 mM glucose, 0.5 mM EDTA and were gently dispersed into single cells by
passage through a 27-gauge needle . The cell suspension was adjusted to 5 X 106 cells/ml
and washed E was added at a ratio of 10 E per nucleated cell . Afterthorough mixing, theCROCKER AND GORDON
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suspension was centrifuged at 200 g for 15 min. The pellet was gently resuspended in 5
ml PBS containing0.5 mM EDTA and the proportionof rosetted cells (>_5 E) was assessed
by phase-contrast microscopy. For further analysis of rosettes, unbound E were removed
by velocity sedimentation; 10" nucleated cells in 5 ml PBS/EDTA were layered over 40
ml PBS containing 0.5 mM EDTA, 5 mM glucose, 3% BSA, and 20 mM Hepes, pH 7.3,
in a 50-ml syringe. After 1 h at room temperature, 5-ml fractions were collected from the
bottom of the syringe and inspected by phase-contrast microscopy. Fractions free of
unbound E were pooled, adjusted to 106 nucleated cells/ml, and cytocentrifuge prepara-
tions were made from 1-ml aliquots. Slides were fixed "wet" in 0.25% glutaraldehyde and
processed for immunocytochemistry.
Immunocytochemistry.
￿
Cell surface antigens on adherent and cytocentrifuge prepara-
tions were detected by immunoperoxidase labeling, using an avidin-biotin detection system
as described (5).
Enzyme Treatment.
￿
Enzymes were added to or dissolved in RPMI as required and 0.5-
ml aliquots were added to Mo on coverslips prewashed with RPMI, or to 25 Al of washed,
packed E. After mixing, cells were incubated for 60 min at 37 °C and digestion was ended
by adding 0.5 ml RPMI + 20% FCS. Coverslips were rinsed nine times by immersion in
RPMI; E were washed three times in PBS by centrifugation.
Assays Measuring Inhibition by Various Reagents.
￿
Sugars, neoglycoproteins, sialoglyco-
proteins, metabolic inhibitors, and EDTA were dissolved at various concentrations in
RPMI. Where necessary, the pH was adjusted to the original value with 0.1 M NaOH,
and 0.5-ml aliquots were added to RBMMon coverslips prewashed with RPMI . E-rosetting
assays were carried out after 15 min preincubation at 37°C in the continued presence of
inhibitors.
Results
Resident Bone Marrow Mo Express a Novel E Receptor.
￿
RBMM were purified
from hematopoietic cell clusters by selective adherence to glass and removal of
attached cells, after collagenase digestion of femoral bone marrow, as described
(5). Two classes of adherent cells were obtained by this procedure. ^-50% were
large, well-spread cells of which >90% were RBMM, staining strongly with the
Mo-specific mAb F4/80 (7). The remaining 50% were small immature neutro-
phils and monocytes, the latter staining weakly with F4/80 . Other adherent cells,
present at ^-1 % of the total, included large, well-spread osteoclasts and fibroblast-
like cells. When these preparations were incubated with unopsonized E, the
majority of RBMM, but none ofthe other adherent cells, rapidly formed rosettes
(Fig. 1 A). In comparison, rosette formation to RPM was rarely observed (Fig.
1B). Binding of E to RBMM was maximal by 30 min of incubation and was not
accompanied by significant ingestion (not shown). This phenomenon was highly
reproducible and was not due to the collagenase or DNase used for their isolation,
since the few RBMM that could be obtained without enzymes rosetted indistin-
guishably and treatment of RPM with collagenase and DNase did not reveal a
"cryptic" form of SER. To examine the fate and stability of bound E, rosettes
were cultivated for varying periods up to 24 h in RPMI or RPMI + 10% FCS.
At all time points examined we did not observe significant ingestion . Instead, E
slowly detached at a rate of ^-5% per hour in RPMI and ^-10% per hour in
RPMI + 10% FCS (not shown).
Arbitrarily, positive rosetting in all experiments was defined by the ability to
bind five or more E. However, the majority of positive RBMM bound >20 E
and in 30 independent experiments we found that an average of 70% ± 15
(mean ± 1 SD ; range, 29-91%) bound ? 5 E. The variability in rosette formation1866
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FIGURE I .
￿
RBMM expressanovel E receptor. Phase contrast micrographs of rosetting assays
with RBMM (A,C, and D) and RPM (B) after adherence and purification on glass coverslips (x
200) . Mo were incubated with a 0.5% vol/vol suspension of E or EIgG in RPMI for 30 min at
37°C . Unbound erythrocytes were removed by repeated immersion of coverslips in RPMI
and cells were fixed in I% glutaraldehyde before examination . (A) Binding ofEto RBMM but
not to contaminating monocytes and neutrophils (arrows) . (B) Low binding ofE to RPM with
only occasional rosettes (arrows) . (C) Inhibition of E binding to RBMM by 20 mM NANA-
lactose . Coverslips were preincubated in NANA-lactose for 15 min at 37°C before addition
ofE. Same experiment as shown in A. (D) Binding of EIgG to RBMM in presence of 20 mM
NANA-lactose, as described in (C) . Monocytes and neutrophils also form rosettes with EIgG
(arrows), unlike with E . Same experiment as in A and C.
seen between experiments was not due to the different batches of E. In addition,
the age (6-12 wk) and sex of mice did not appear to affect the ability ofRBMM
to form rosettes . To determine whether SER was present among other inbred
mouse strains, RBMM were isolated from ASN, CBA T6T6, and BALB/c mice .
There were no significant differences in expression of SER and in all cases,
ingestion of rosetted E was <I% of those bound .
To confirm the specificity of SER for M0, rosetting was also carried out on
cells in suspension . In three independent experiments with collagenase-digested
bone marrow, 1-3% of nucleated cells formed rosettes, 100% of which were
RBMM as assessed by size, morphology, and immunoperoxidase labeling with
F4/80 (not shown) . The proportion ofRBMM that formed rosettes in suspension
was 80-90%, values that were simliar to those seen with adherent RBMM . These
results therefore suggested that SER is Mo restricted .
Characteristics of the Interaction between RBMM and E .
￿
To investigate the
nature of the surface molecules on RBMM and E that mediate rosetting we
tested various conditions and reagents for their ability to affect binding. These
included temperature and cation dependence, effects of metabolic inhibitors,w
n\
c
a c
a
m
e
100
50
100
50
CROCKER AND GORDON
￿
1867
RBMM Pretreated
E pretreated
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FIGURE 2.
￿
Differential effect of trypsin (filled circle) or neuraminidase (open circle) pretreat-
ment of RBMM (top) or E (bottom) on rosette formation. The data show mean values of
duplicate coverslips. Individual counts were <10% of the mean and are omitted for clarity.
Simliar results were obtained in three independent experiments.
and pretreatment of RBMM or E with proteolytic enzymes or V. cholerae
neuraminidase (Fig. 2) . Rosetting was unaffected over the temperature range 0-
37'C (0, 4, 22, and 37 °C) and was independentof divalent cations, sinceaddition
of 0-10 mM EDTA to RPMI did not influence binding. Binding was also
unaltered in calcium and magnesium-free PBS containing 1 mM EDTA, although
RBMM became rounded under these conditions (not shown). Finally, rosetting
was unaffected in the presence of the metabolic inhibitors sodium azide and
iodoacetate up to 10 mM .
SER was found to be labile to S. aureus V8 protease and trypsin (Fig. 2, top),
but resistant to the collagenase and DNase used in isolation of RBMM . The dose-
dependent inhibition observed with trypsin was not due to a toxic effect on
RBMM since rosetting to antibody-coated E was unimpaired, presumably via the
trypsin-resistant Fc receptor (12, not shown). In contrast to protease and trypsin,
treatment of RBMM with neuraminidase resulted in enhancement of rosetting
(Fig. 2, top). When E were pretreated with trypsin or neuraminidase, we saw
precisely the opposite pattern (Fig. 2, bottom). Thus, trypsinization led to a dose-
dependent enhancement of binding, whereas neuraminidase treatment inhibited
binding by up to 90% at the lowest concentration tested, 6 U/ml. Similar results
were obtained with V. cholerae neuraminidase supplied by Calbiochem-Behring,
which inhibited >90% at an equivalent low concentration (<0.01 Behringwerke1868
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FIGURE 3 .
￿
Inhibition by NANA-lactose of E (filled circles) but not EIgG (open circles) binding
to RBMM. Data show means ± 1 SD of triplicate coverslips. Similar results were obtained in
two independent experiments. No inhibition was seen with the following mono- and disaccha-
rides, all tested at 100 MM; D-glucose, D-galactose, N-acetyl-D-glucosamine, N-acetyl-D-galac-
tosamine, D-fucose, D-mannose, N-acetyl neuraminic acid, a-lactose, and ,B-lactose.
U/ml). Sialylated components on the surface of E therefore appeared to be
required for the interaction with SER on RBMM .
Lectin-like Properties of SER.
￿
To investigate the possible lectin-like nature of
SER, we first determined whether various sugars could inhibit rosetting (for
details see legend to Fig. 3). Of the mono- and disaccharides studied, none had
any effect on rosetting at concentrations up to 100 mM. However, the trisac-
charide NANA-lactose, purified either from human or bovine colostrum, gave
50% inhibition at 5-10 mM (Figs. 1 C and 3) . 35 mM was required for 100%
inhibition . This was not due to nonspecific toxic effects, since RBMM treated
with NANA-lactose were morphologically intact (Fig. 1 C) and rosette formation
with EIgG was virtually unaffected (Fig. 1 D and Fig. 3).
In view of the seeming importance of sialylated components on E, we also
tested the inhibitory effect of the mono- and disialylated gangliosides GM 1 and
GD 1a, respectively, and of the richly sialylated glycoproteins fetuin, orosomucoid
and ovine submaxillary mucin. GM 1 gave no inhibition at the highest concentra-
tion tested (1,000 1Ag/ml, 650 ,AM) but GD1a inhibited binding by 50% at 20
jug/ml (1 I AM) and by 100% at ^-100 Ag/ml. Inhibition was not accompanied by
toxic effects and RBMM remained fully viable throughout . A 30-min preincu-
bation of RBMM with GDla, followed by washout, resulted in inhibition of
rosetting at similar concentrations. This suggests that GDIa mediates its effects
by interacting with RBMM . Of the sialoglycoproteins tested, fetuin or oroso-
mucoid at concentrations up to 1,000 Ag/ml (20 AM) had no effect on rosetting,
but ovine submaxillary mucin gave 50% inhibition at 500 tag/ml (3 AM). This
was not thought to be significant since higher concentrations were toxic.
Previously characterised lectin-like receptors on Mo include the mannosyl-
fucosyl receptor (MFR) and galactose receptor (13, 14). To exclude a role for
either of these in rosette formation, we tested the effect of specific neoglycocon
jugate inhibitors . We saw no inhibition with either mannosylated or galactosy-
lated BSA at 100 hg/ml (1 .5 AM), concentrations that completely inhibit MFR
andthe galactosereceptor, respectively (15, 16). In addition, pre- or coincubationCROCKER AND GORDON
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TABLE I
Inverse Expression of SER and Ia Antigens on RBMM
* Expression of la antigens on individual RBMM, determined by immunocytochemistry using mAb M5/114 (anti-I-AbAq, I-E0),
$ Total number of RBMM counted on duplicate coverslips.
3 I-Ab haplotype.
1 Mean t 1 SD derived from counts of E on individual RBMM.
I-Ad/I-Ed haplotype.
with 100% homologous plasma or serum had no detectable effect on binding of
E. Finally, saturating concentrations of the mAbs F4/80, M5/114 (Ia antigen),
2AG2 (FcR I1), or M1/70 (CR3) did not affect rosetting.
Inverse Expression of SER and Ia Antigens on RBMM.
￿
The heterogeneity in
expression of SER on RBMM was a noticeable feature in all experiments. As
heterogeneity of a similar kind had previously been seen (5) for expression of la
antigens on RBMM, we investigated the relationship between these two markers
by employing a double-labeling procedure of rosetting followed by immuno-
peroxidase staining with mAb M5/114 to detect la antigens. Control experiments
showed that prior rosetting with E did not alter the proportion of RBMM-
expressing la antigens, as assessed by immunocytochemistry (not shown). In four
independent experiments theproportion of RBMM expressing Ia antigens varied
from 21-64% . In each experiment there was a clear inverse correlation between
expression of SER and la antigens on RBMM isolated from either C57BL/6 (H-
2b) or BALB/c (H-2d) mouse strains (Table I) . This was most clear if the la
population was compared with the strongly Ia+ RBMM. Thus, in all experiments,
96-100% of la- RBMM bound >_5 E while only 3-33% of the strongly Ia+
population formed rosettes. The weakly Ia+ population showed variable E
rosetting, although the mean values of E bound per RBMM were intermediate
between the la- and strongly Ia+ RBMM subpopulations (Table 1).
SER Is Expressed Transiently on RBMM.
￿
During attempts to show biosynthesis
of SER by RBMM it was found that reexpression after trypsinization did not
exceed 10% of initial levels over a 48-h period of cultivation in RPMI plus 10%
FCS (not shown). However, examination of SER expression on RBMM not
treated with trypsin also showed that binding activity was gradually lost over a
3-d period with a half-life of ^-24 h (Fig . 4). The monocytes that initially
contaminated the RBMM preparations survived poorly and were not included
in the analysis. The loss of SER was accompanied by other phenotypic changes,
which included increased expression of Mac-1 antigen, initially undetectable, and
a transient increase in expression of la antigen. There was no change in expres-
sion of F4/80 antigen, which remained on 100% of RBMM throughout culture
(Fig. 4). RBMM also exhibited morphological changes during cultivation, with
retraction of the extensive plasma membrane processes (not shown). This was
la negative RBMM* Weak la' RBMM Strong la' RBMM
Exp. Strain nt Total
RBMM
;~5
E
E per
RBMM
Total
RBMM
;~5
E
E per
RBMM
Total
RBMM
a5
E
E per
RBMM
1 C57BL/6# 234 79 96 47 t 291 13 72 9t17 8 32 2 ± 3
2 C57BL/6 215 72 98 50 t 41 16 81 25 t 22 12 12 2 t 3
3 C57BL/6 138 46 97 50 t 33 14 33 16 t 16 40 33 4 ± 5
4 BALB/0 248 36 99 43 t 27 34 77 23 t 21 30 3 1 t 21870
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FIGURE 4.
￿
Decline in expression of SER (filled circles) on RBMM cultivated in RPMI plus
10% FCS compared with expression of la (open triangles), Mac-1 (filled triangles), and 174/80
(open circles) antigens. The data show mean percentage of RBMM* for each marker (percent
binding >>-5 E or percent with clearly visible diaminobenzidine reaction product). 200 RBMM
were counted on each of duplicate coverslips; contaminating monocytes were not included.
Individual counts were within 10% of mean and are omitted for clarity. Similar results were
obtained in three independent experiments.
accompanied by gradual detachment of nonviable RBMM with -50% remaining
at 72 h. Precisely the same pattern of phenotypic changes was seen in three
independent experiments. In conclusion, SER levels declined in culture with a
half-life of ^-24 h. This could not be accounted for by a population shift and was
accompanied by changes in expression of Mac-1 and la antigens, but not 174/80.
Distribution of SER on Monocytes and Various Mto Populations.
￿
The properties
and differential expression of SER on RBMM compared with RPM suggested
that it could be involved in adhesive cellular interactions within bone marrow. It
was therefore important to determine the distribution of SER on other deeply
embedded stromal tissue MO populations and compare this with expression on
other "free" MO obtained by lavage from serous cavities and bronchoalveolar
spaces (Table II). To distinguish M(p from other adherent cells, preparations
were rosetted and then stained immunocytochemically with the Mo-specific mAb,
F4/80. Control experiments showed that immunocytochemical detection of
174/80 was unaffected by prior rosetting (not shown). This double-labeling
procedure was essential with stromal tissue Mo isolated by collagenase digestion
from liver, spleen, mesenteric lymph nodes, and thymus, which were often
contaminated by a variety of other cell types (e . g., endothelial cells, fibroblasts,
dendritic cells, and epithelial cells).
^-50% of Kupffer cells were SER+, but rosetting was of lower intensity than
that seen with RBMM . Contaminating 174/80- endothelial cells did not bind E.
With spleen, 25-55% of the 174/80+ adherent cells formed rosettes, with similar
intensity to that of Kupffer cells. This was seen predominantly on the large, well-
spread population and was normally absent from the smaller immature MO and
monocytes. Occasionally, well-spread 174/80- cells with M¢ morphology formed
rosettes, but 174/80- cells with the morphology of Steinman-Cohn spleen den-CROCKER AND GORDON
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TABLE 11
Expression ofSER on Different MO Populations and Monocytes after
Adherence to Glass
* Based on counts of duplicate coverslips in each experiment and includes
small F4/80* Mo and monocyte-like cells. 100-200 F4/80' cells counted
per coverslip.
Positive rosetting of E to F4/80- cells was seen only in spleen where it
constituted ^-5% of total rosettes.
4 Range ofvalues from the indicated number ofexperiments.
u Mean ± 1 SD of individual coverslips (two perexperiment).
dritic cells (17) did notbind E(not shown). With collagenase-digested mesenteric
lymph nodes, rosetting was again seen predominantly on the large, well-spread
stromal Mo and was of similar intensity to that of RBMM . With adult thymus,
the majority of F4/80' adherent cells were small cells resembling immature MO
and expression of SER was restricted to the few stromal-type MO. With the
peritoneal cavity, a variable, but usually low degree of rosetting (<10%), was
seen with either resident, inflammatory, or activated Mo. Pleural Mo, bronchoal-
veolar Mo, and blood monocytes were all SER-. Finally, in two experiments with
spleen, rosetting was also carried out in suspension. 5-6% of nucleated spleen
cells bound >_5 E, and 90% of the rosetting cells were F4/80+. The F4/80-,
SER+ subpopulation consisted of large phagocytic cells with oval nuclei and a
nuclear/cytoplasmic ratio of «1 . They may correspond to F4/80- marginal zone
MO (18). Cells with lymphocyte morphology did not bind E.
In conclusion, SER was expressed differentially on other stromal tissue M¢
populations, in addition to RBMM, and appeared to be MO specific. Of the
tissues examined, we saw the most intense rosetting on RBMM and mesenteric
lymph node MO; intermediate levels with liver Mo and stromal splenic MO; but
we saw low levels of SER on monocytes and Mo isolated from the thymus, serous
cavities, and alveolar spaces.
Discussion
In this study we have characterized a novel lectin-like, Mo-restricted receptor,
with specificity for sialylated ligand(s) on sheep E. This hemagglutinin mediates
Tissue Number of
experiments
Adherent cells
F4/80'*
F4/80' cells bind-
ing 35 E*,$
Bone marrow 4 60-814 64 ± III
Liver 4 50-90 51 ± 9
Mesenteric lymph node 3 53-60 55 ± 11
Spleen 4 28-65 29 ± 9
Thymus 2 55-65 3 ± 1
Peritoneal cavity
Resident 9 90-100 7 ± 6
Thioglycollate 10 95-100 3 ± 4
BCG-activated 2 95-100 6 ± 2
C. parvum-activated 2 95-100 5 ± 2
Pleural cavity 3 90-100 0 ± 0
Bronchoalveolarspaces 3 95-100 0 ± 0
Blood 5 80-90 0 ± 01872
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binding, but not ingestion, of E and is differentially expressed, being present at
high levels on a majority of murine RBMM and stromal lymph node macro-
phages, at intermediate levels on liver and stromal splenic MO, but at low or
undetectable levels on blood monocytes and thymic, peritoneal, pleural, and
bronchoalveolar MO. We propose that this hemagglutinin is involved in non-
phagocytic cellular interactions within tissues.
E are commonly used as carriers of Ig or complement fragments to detect FcR
and complement receptors, respectively, on myeloid and lymphoid cells. It is
therefore, perhaps, surprising that background rosetting with unopsonized con-
trol E has not been reported in previous studies of murine tissue MO. However,
effective isolation of MO from solid tissues requires the use of tissue-dispersing
enzymes so that methods based on mechanical disruption would select for the
nonstellate, SER- MO. Even in those studies that use dispersing enzymes, non-
specific proteases, either in the enzyme preparation or released from tissues,
could remove the receptor. In addition, since bound E are not ingested via SER,
they could be easily removed during pipetting procedures, which were avoided
in our assays.
In contrast to the mouse, the formation of rosettes with unopsonized E is a
well-recognized phenomenon with human T lymphocytes (19, 20). By several
criteria, the ligand on E recognized by human T cells appears to be distinct from
that recognized by murine macrophages. These include the converse effects of
neuraminidase and trypsin pretreatment of E as well as the temperature and
metabolic requirements for rosette formation with human T cells (21). The
precise nature of the ligand on E that interacts with murine macrophages is
unclear, although the extreme sensitivity to neuraminidase provides evidence
that sialic acid is a minimal requirement. It is possible that the recognized sialic
acid is associated with a ganglioside rather than a glycopeptide, since there was
potent inhibition by the ganglioside, GD1a, but not by a variety of heavily
sialylated glycoproteins. The inhibition mediated by GD1a was unlikely to be a
nonspecific detergent effect since high concentrations of the related ganglioside,
GM 1, gave no inhibition. We have not carriedoutan extensive survey of different
gangliosides because the mechanism of inhibition is likely to be complex and for
meaningful comparisons it is necessary to use ceramide-free oligosaccharides. It
is probable that the inhibition mediated by millimolar concentrations of the
trisaccharide, NANA-lactose, reflects a low-affinity interaction with SER. This
could not be simply a charge effect, because N-acetyl neuraminic acid failed to
inhibitbinding at similar concentrations, thereby implying that either the correct
anomeric structure of sialic acid (22) or adjoining galactose and/or glucose
residues are required. Further studies are clearly needed to define the structural
requirements for optimal inhibition of SER.
SER appears to be unrelated to the previously well-characterized MO lectin-
like receptors, MFR, and galactose receptor (13, 14), but it may be related to
agglutinins described on rat bronchoalveolar and peritoneal MO and on the
murine Mo-like cell line, Mml, which recognize sialylated components on gan-
glioside-treated E and quail erythrocytes, respectively (23, 24). Although the
properties of both receptors are similar to SER, the differential expression on
tissue MO populations was not reported previously.CROCKER AND GORDON
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The lability of SERto trypsin suggests it is a protein, but because of itstransient
expression in culture, we could not determine whether RBMM synthesize or
acquire the hemagglutinin. In recent experiments (our unpublished observa-
tions), however, we have found that SER can be induced readily by cultivation
in the presence of mouse serum, rather than in FCS as used here, and that
reexpression after trypsinisation is sensitive to cycloheximide, suggesting that
RBMM synthesize SER. In the present study, the loss of SER was accompanied
by changes in expression of Mac-1 and la antigens that probably reflect rapid in
vitrodedifferentiation. At the beginningofculture, however, there was a striking
inverse correlation between expression of SER and la antigens that points to
differential in vivo regulation, the significance of which is unknown.
In conclusion, the high levels of SER on deeply embedded stromal M¢ and
the absence of ingestion suggest that the hemagglutinin may be involved in
nonphagocytic interactions within tissues. In bone marrow, for example, SER on
RBMM could interact with the attached hematopoietic cells to influence their
growth and differentiation, a possibility that has recently been strengthened by
our finding that bone marrow cells express an appropriate sialylated ligand (our
unpublished observations). The heterogeneity in SER levels detected among
various tissues may reflect the differing proportions of immature macrophages
as well as the effects of local and systemic modulators that regulate SER expres-
sion. Interestingly, the MO populations that exhibited lowest levels of SER were
obtained by lavage from serous cavities or bronchoalveolar spaces. This implies
that the majority of SER-bearing Mo are "fixed" within tissues, either through
adhesion to extracellular matrix components or by cellular interactions. Further
studiesare needed to establish whether SER is expressed after fixation or whether
it contributes directly to this process.
Summary
We describe a novel hemagglutinin which is differentially expressedon murine
stromal tissue macrophages. Resident bone marrow macrophages (RBMM),
which are physically associated with immature, proliferating hematopoietic cells
in vivo, formed striking rosettes with unopsonized sheep erythrocytes (E) in
vitro, unlike resident peritoneal macrophages (RPM). Binding of E was macro-
phage (MO) specific, not accompanied by ingestion and independent of temper-
ature (0-37'C), divalent cations, and the metabolic inhibitors azide and iodoac-
etate. Pretreatment of RBMM with trypsin prevented rosette formation, but
neuraminidase enhanced it. Conversely, binding was virtually abrogated if E
were pretreated with neuraminidase, whereas trypsin pretreatment of the ligand
resulted in a slight enhancement. The lectin-like nature of the E receptor (SER),
with specificity for sialylated glycoconjugates, was consistent with the inhibition
of binding we saw with neuraminyllactose or the ganglioside GDla (50% inhibi-
tion at 5-10 mM and I 1 AM, respectively).
Expression of SERon freshly isolated RBMM was heterogeneousand exhibited
a striking inverse correlation with expression of la antigens. During cultivation
in 10% FCS, levels of SER on RBMM declined with a half-life of -24 h. Other
cell surface changes induced by cultivation included a transient increase in
expression of la antigen and acquisition of Mac-1 . To determine whether SER1874
￿
MACROPHAGE SHEEP ERYTHROCYTE RECEPTOR
was expressed on other stromal Mo populations, adherent cells were isolated
from various tissues by collagenase digestion or lavage. Binding of E was highest
on RBMM and lymph node stromal M0, at intermediate levels on Kupffer cells
and splenic stromal M0, but was low or undetectable on blood monocytes and
thymic, peritoneal, pleural, and bronchoalveolar MO. SER therefore appeared
to be expressed on certain Mo populations embedded in solid tissues but was
largely absent from Mo recoverable by lavage. Its absence from monocytes
implies that SER is acquired by MO after entering tissues where it may perform
adhesive functions. In bone marrow, SER on RBMM could interact with an
appropriate sialylated ligand on murine hematopoietic cells, and could influence
their rate of growth and differentiation.
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